Miller-Fisher Syndrome Unveiled in the Presence of Cholangiocarcinoma

被引:0
作者
Hakobyan, Narek [1 ]
Yadav, Ruchi
Pokhrel, Akriti [1 ]
Wasifuddin, Mustafa [1 ]
John, Michaela J. [3 ]
Yadav, Siddharth [4 ]
Boris, Avezbakiyev [2 ]
机构
[1] Brookdale Univ Hosp & Med Ctr, Internal Med, Brooklyn, NY 11212 USA
[2] Brookdale Univ Hosp & Med Ctr, Hematol & Oncol, Brooklyn, NY USA
[3] St Georges Univ, Internal Med, Sch Med, Brooklyn, NY 11201 USA
[4] Bronx High Sch Sci, Sch Hlth Sci, Bronx, NY USA
关键词
bickerstaff brainstem encephalitis; guillain-barre syndreome; distal cholangiocarcinoma; intrahepatic cholangiocarcinoma; miller-fisher syndrome; GUILLAIN-BARRE-SYNDROME;
D O I
10.7759/cureus.49016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Miller-Fisher syndrome (MFS) is a rare variant of Guillain-Barre syndrome, characterized by ataxia, areflexia, ophthalmoplegia, and possible facial, swallowing and limb weakness alongside respiratory failure. Variations within MFS may include respiratory and limb weakness and Bickerstaff brainstem encephalitis (BBE), marked by altered consciousness, ataxia, ophthalmoparesis, and paradoxical hyperreflexia. MFS can emerge in both children and adults, often following bacterial or viral illness. While autoimmune-driven nerve damage occurs, most MFS patients recover within six months without specific treatment, with a low risk of lasting neurological deficits or relapses. Rarely fatal, MFS's co-occurrence with cholangiocarcinoma (CCA) presents unique management challenges. CCA, primarily affecting bile ducts, has a bleak prognosis; surgical resection offers limited cure potential due to late-stage detection and high recurrence rates. Advances in CCA's molecular understanding have led to novel diagnostic and therapeutic approaches, requiring a comprehensive interdisciplinary care approach for optimal MFS and CCA management outcomes.Herein, we present a 50-year-old male with a complex medical history who was admitted to the hospital due to abdominal discomfort, nausea, vomiting, and ascites. Imaging revealed pneumonia and secondary bacterial peritonitis. Later, he developed neurological symptoms, including weakness, gait abnormalities, and brainstem symptoms, leading to the diagnosis of MFS. Despite treatment efforts, his condition deteriorated, leading to acute liver failure and unexplained anasarca. N-acetyl cysteine was initiated for liver issues. Neurologically, he showed quadriparesis and areflexia. Intravenous immunoglobulin (IVIG) treatment improved his neurological symptoms but worsened gastrointestinal issues, including ileus and elevated CA19-9 levels, suggesting a potential carcinoma. A liver biopsy was performed. After IVIG treatment, he experienced widespread discomfort, emotional unresponsiveness, swallowing difficulties, and aspiration risk, ultimately leading to his demise.
引用
收藏
页数:5
相关论文
共 15 条
  • [1] BERLIT P, 1992, J CLIN NEURO-OPHTHAL, V12, P57
  • [2] Clinical diagnosis and staging of cholangiocarcinoma
    Blechacz, Boris
    Komuta, Mina
    Roskams, Tania
    Gores, Gregory J.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (09) : 512 - 522
  • [3] GUILLAIN-BARRE-SYNDROME AS AN EXTRAINTESTINAL MANIFESTATION OF CROHNS-DISEASE
    DELAFUENTEFERNANDEZ, R
    RUBIONAZABAL, E
    DELAIGLESIAMARTINEZ, F
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1995, 71 (837) : 437 - 438
  • [4] A Rare Case of Miller Fisher Syndrome in a 45- Year-Old Female
    Duvuru, Ruthwik
    Raju, Shivani
    Nawaz, Faisal
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [5] Fujimura H, 2013, HAND CLINIC, V115, P383, DOI 10.1016/B978-0-444-52902-2.00021-7
  • [6] Clinical and immunological spectrum of the Miller Fisher syndrome
    Lo, Y. L.
    [J]. MUSCLE & NERVE, 2007, 36 (05) : 615 - 627
  • [7] Real-world treatment of adult patients with Guillain-Barre syndrome over the last two decades
    Rath, Jakob
    Zulehner, Gudrun
    Schober, Bernadette
    Grisold, Anna
    Krenn, Martin
    Cetin, Hakan
    Zimprich, Fritz
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Cholangiocarcinoma
    Razumilava, Nataliya
    Gores, Gregory J.
    [J]. LANCET, 2014, 383 (9935) : 2168 - 2179
  • [9] Cholangiocarcinoma - evolving concepts and therapeutic strategies
    Rizvi, Sumera
    Khan, Shahid A.
    Hallemeier, Christopher L.
    Kelley, Robin K.
    Gores, Gregory J.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (02) : 95 - 111
  • [10] Rocha Cabrero F., 2022, StatPearls